Traditional Chinese medicine composition for treating rheumatic heart disease

Abstract

The invention discloses a traditional Chinese medicine composition for treating rheumatic heart disease. The traditional Chinese medicine composition is prepared from the following raw materials by weight: 3-8g of lotus seed, 3-8g of fructus gardenia, 5-15g of radix polygonati officinalis, 5-15g of schisandra chinensis, 5-15g of radix stephaniae tetrandrae, 5-15g of fructus aurantii immaturus, 5-15g of radix ophiopogonis, 5-15g of cassia twig, 5-15g of radix bupleuri, 5-15g of cortex acanthopanacis, 5-15g of radix paeoniae rubra, 5-15g of angelica sinensis, 10-20g of radix curcumae, 10-20g of semen plantaginis, 10-20g of codonopsis pilosula, 10-20g of radix salviae miltiorrhizae, 10-20g of radix rehmanniae, 10-20g of radix stephaniae tetrandrae, 10-20g of raw gypsum, 10-20g of radix gentianae macrophyllae, 15-25g of radix polygoni multiflori, 15-25g of loranthus parasiticus, 15-25g of radix astragali and 3-8g of liquorice. By combining the medicines, the composition has a synergistic effect; the traditional Chinese medicine composition for treating rheumatic heart disease has the functions of invigorating qi and enriching blood, warming yang and restoring pulse, promoting circulation and removing stasis and consolidating body resistance and nourishing vigour; moreover, the medicines have the advantages of no side effect to the body, no negative influence on the health of the patients and the like. By virtue of clinical experiment, a relatively high cure rate is achieved.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating rheumatic heart disease, in particular to a traditional Chinese medicine composition for treating rheumatic heart disease, which belongs to the technical field of traditional Chinese medicine. Background technique [0002] Rheumatic heart disease is the consequence of rheumatic lesions invading the heart. It refers to a kind of heart disease left over from acute rheumatic carditis, mainly with heart valve lesions. It is more common in the mitral valve, and several valves can also be involved at the same time. The disease occurs mostly in young adults aged 20-45, more women than men. The clinical symptoms of this disease include chest tightness, chest pain, shortness of breath, palpitation, dizziness, fatigue, arrhythmia, dyspnea, aggravation of movement, severe cases of body edema, angina pectoris, dizziness, heart failure, and even sudden death, becoming a powerful enemy that endange...

AI Technical Summary

Problems solved by technology

[0003] The treatment of rheumatic heart disease is mostly based on surgical replacement of artificial valves, which is expensive and risky. Usually, after 3-5 years of valve replacement, other valves are damaged again, and surgery is still required, which brings physical and economic burdens to patients. to heavy losses

Therefore, the treatment of this disease should start with the correction of heart failure, but most of the existing Chinese and Western medicines for the treatment of rheumatic heart disease only control the disease, and cannot completely eliminate the root cause of heart valve disease